HOME >> MEDICINE >> NEWS
New drug protects against the hardening of arteries

Atherosclerosis, a leading cause of morbidity and mortality in Western nations, is caused by the accumulation of cholesterol-rich lipoproteins that adhere to vessel walls and develop into macrophages. These macrophages, laden with lipid, cause inflammation in the vessel and, over time, formation of a lesion. A family of proteins known as PPARs (PPARalpha, PPARbeta, and PPARgamma) are expressed by cells of the artery wall and drugs that activate PPARalpha and PPARgamma (known as PPAR agonists) are used to treat high lipid levels (such as cholesterol and triglycerides), and type 2 diabetes, respectively. The presence of PPARs in the vessel wall has prompted researchers to investigate the effects of PPAR agonists on atherosclerosis in mice. While studies have shown that PPARgamma agonists are beneficial in the treatment of atherosclerosis in mice, the role of other members of this protein family have remained unclear.

In the December 1 issue of the Journal of Clinical Investigation, Andrew Li and colleagues from the University of California, San Diego compare the effects of PPARalpha, PPARbeta, and PPARgamma agonists on the development of atherosclerosis in a mouse model of this disease. They observed profound protective effects of the PPARalpha agonist GW7647, comparable to the PPARgamma agonist rosiglitazone that is currently used to treat type 2 diabetes. GW7647 also reduced weight gain, and insulin and lipoprotein levels. In contrast, lesion development was not inhibited by a PPARbeta agonist.

In an accompanying commentary, Peter Tontonoz and Antonio Castrillo from the University of California, Los Angeles discuss the mechanism described by Li and colleagues by which lipid accumulation is reduced by these agonists, thereby giving us a greater understanding of the roles of PPAR family members in atherosclerosis. Most importantly, the study highlights that the use of a drug (or drugs) that target multiple PPARs, particularly PPARalpha and PPARgamma,
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-0497
Journal of Clinical Investigation
1-Dec-2004


Page: 1 2

Related medicine news :

1. Red wine protects the heart
2. Component of green tea protects injured livers in mice
3. Substance protects resilient staph bacteria
4. Gene vaccine protects mice against development of Her2/neu breast cancer
5. Blocking molecules protects health of implants
6. Good parenting protects against chronic illness says professor of public health
7. Exercising limbs protects brain cells affected by Parkinsons, study in rodents shows
8. Mechanism found that protects aggressive melanoma from angiogenesis inhibitors
9. Chicken pox vaccine saves $$, protects whole population
10. Diet of worms protects against bowel cancer
11. NIAID vaccine protects against SARS virus infection in mice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New drug protects against the hardening arteries

(Date:10/31/2014)... In an effort to expand services and improve efficiency ... will soon offer orthodontics at his Oral & Maxillofacial Surgery ... , To build upon the high degree of care and ... known for, Dr. Jamali is welcoming an orthodontist that is ... as UCLA, Stanford and UCSF. He added that the new ...
(Date:10/31/2014)... 2014 Phoenix dentist , Dr. Christy, ... November. Whether patients simply need routine care or have a ... than now to get that necessary care. The right dental ... routine and even essential treatments due to financial concerns. Throughout ... on any treatments offered by the team at Christy Dental ...
(Date:10/31/2014)... Uniwigs.com newly arrived flip in hair extensions are ... itself around people’s heads with a transparent miracle wire undetectable ... comes with adjustable loops, which are improved over the basic ... now adjust the wire to best fit the size of ... generation of flip ins, they simply need to adjust the ...
(Date:10/31/2014)... 31, 2014 Med-Care Diabetic & Medical ... highest principles of patient care and service, announced a ... and wellness website, to provide an online Diabetes ... , The Diabetes Health Center will provide topical information ... living with diabetes. Content will feature advice from leading ...
(Date:10/31/2014)... FRIDAY, Oct. 31, 2014 (HealthDay News) -- A few simple ... cope with, a sleep expert says. "Adjusting to the ... bit easier than handling the time change in the spring. ... sleep for the fall time change," Dr. Praveen Rudraraju, director ... in Mount Kisco, N.Y., said in a hospital news release. ...
Breaking Medicine News(10 mins):Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2Health News:UniWigs Unveiles New Generation of Flip In Hair Extensions 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:Make the Most of This Weekend's Time Change 2
(Date:10/31/2014)... 31, 2014 Oramed Pharmaceuticals ... company focused on the development of oral drug ... a conference call to discuss the clinical results ... the company,s proprietary oral insulin capsules, to treat ... at 10:00 a.m. Eastern time. Shareholders ...
(Date:10/31/2014)... 31, 2014 Investor-Edge has initiated ... NSPH ), Isis Pharmaceuticals Inc. (NASDAQ: ... ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow ...
(Date:10/31/2014)... 3, 2014 British Journal ... BPH to discuss "male orgasmic dysfunction" with their doctor ... treat prostate symptoms while preserving sexual function   ... publication of a paper in the British Journal of ... prostate to discuss with their doctors the likely impact ...
Breaking Medicine Technology:Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2
Cached News: